Follow
Björn Nodin
Björn Nodin
Verified email at med.lu.se
Title
Cited by
Cited by
Year
Prognostic impact of tumour‐infiltrating B cells and plasma cells in colorectal cancer
J Berntsson, B Nodin, J Eberhard, P Micke, K Jirström
International journal of cancer 139 (5), 1129-1139, 2016
2362016
A cohort study of the prognostic and treatment predictive value of SATB2 expression in colorectal cancer
J Eberhard, A Gaber, S Wangefjord, B Nodin, M Uhlen, ...
British journal of cancer 106 (5), 931-938, 2012
1252012
Prognostic impact of tumour-associated B cells and plasma cells in epithelial ovarian cancer
S Lundgren, J Berntsson, B Nodin, P Micke, K Jirström
Journal of ovarian research 9, 1-9, 2016
1092016
Overexpression of podocalyxin-like protein is an independent factor of poor prognosis in colorectal cancer
A Larsson, ME Johansson, S Wangefjord, A Gaber, B Nodin, ...
British journal of cancer 105 (5), 666-672, 2011
1092011
Expression of the RNA-binding protein RBM3 is associated with a favourable prognosis and cisplatin sensitivity in epithelial ovarian cancer
Å Ehlén, DJ Brennan, B Nodin, DP O'connor, J Eberhard, ...
Journal of translational medicine 8, 1-12, 2010
1032010
Expression of programmed cell death protein 1 (PD-1) and its ligand PD-L1 in colorectal cancer: relationship with sidedness and prognosis
J Berntsson, J Eberhard, B Nodin, K Leandersson, AH Larsson, K Jirström
Oncoimmunology 7 (8), e1465165, 2018
892018
The prognostic factors and multiple biomarkers in young patients with colorectal cancer
MJ Wang, J Ping, Y Li, G Adell, G Arbman, B Nodin, WJ Meng, H Zhang, ...
Scientific reports 5 (1), 10645, 2015
842015
Molecular and genetic diversity in the metastatic process of melanoma
K Harbst, M Lauss, H Cirenajwis, C Winter, J Howlin, T Törngren, A Kvist, ...
The Journal of pathology 233 (1), 39-50, 2014
782014
Comprehensive DNA methylation study identifies novel progression-related and prognostic markers for cutaneous melanoma
J Wouters, M Vizoso, A Martinez-Cardus, FJ Carmona, O Govaere, ...
BMC medicine 15, 1-16, 2017
762017
The impact of the fourth edition of the WHO classification of lung tumours on histological classification of resected pulmonary NSCCs
P Micke, JSM Mattsson, D Djureinovic, B Nodin, K Jirström, L Tran, ...
Journal of Thoracic Oncology 11 (6), 862-872, 2016
762016
The clinical impact of tumour‐infiltrating lymphocytes in colorectal cancer differs by anatomical subsite: A cohort study
J Berntsson, MC Svensson, K Leandersson, B Nodin, P Micke, ...
International journal of cancer 141 (8), 1654-1666, 2017
722017
Associations of beta-catenin alterations and MSI screening status with expression of key cell cycle regulating proteins and survival from colorectal cancer
S Wangefjord, J Brändstedt, KE Lindquist, B Nodin, K Jirström, J Eberhard
Diagnostic pathology 8, 1-12, 2013
722013
Low RBM3 protein expression correlates with tumour progression and poor prognosis in malignant melanoma: an analysis of 215 cases from the Malmö Diet and Cancer Study
L Jonsson, J Bergman, B Nodin, J Manjer, F Pontén, M Uhlén, K Jirström
Journal of translational medicine 9, 1-9, 2011
712011
RBM3-regulated genes promote DNA integrity and affect clinical outcome in epithelial ovarian cancer
Õ Ehlén, B Nodin, E Rexhepaj, J Brändstedt, M Uhlén, ...
Translational oncology 4 (4), 212-IN1, 2011
712011
Molecular correlates and prognostic significance of SATB1 expression in colorectal cancer
B Nodin, H Johannesson, S Wangefjord, DP O’Connor, KE Lindquist, ...
Diagnostic pathology 7, 1-9, 2012
682012
High MCM3 expression is an independent biomarker of poor prognosis and correlates with reduced RBM3 expression in a prospective cohort of malignant melanoma
B Nodin, M Fridberg, L Jonsson, J Bergman, M Uhlén, K Jirström
Diagnostic pathology 7, 1-10, 2012
632012
Gender, anthropometric factors and risk of colorectal cancer with particular reference to tumour location and TNM stage: a cohort study
J Brändstedt, S Wangefjord, B Nodin, A Gaber, J Manjer, K Jirström
Biology of sex differences 3, 1-13, 2012
632012
Membranous expression of podocalyxin-like protein is an independent factor of poor prognosis in urothelial bladder cancer
K Boman, AH Larsson, U Segersten, E Kuteeva, H Johannesson, B Nodin, ...
British journal of cancer 108 (11), 2321-2328, 2013
602013
High nuclear RBM3 expression is associated with an improved prognosis in colorectal cancer
B Hjelm, DJ Brennan, N Zendehrokh, J Eberhard, B Nodin, A Gaber, ...
PROTEOMICS–Clinical Applications 5 (11‐12), 624-635, 2011
602011
Validation of podocalyxin-like protein as a biomarker of poor prognosis in colorectal cancer
A Larsson, M Fridberg, A Gaber, B Nodin, P Levéen, G Jönsson, M Uhlén, ...
BMC cancer 12, 1-9, 2012
562012
The system can't perform the operation now. Try again later.
Articles 1–20